Kaiser Permanente Bellflower Med Ctr Orchard/Imperial Outpatient Clinic
-
Services:
- Comprehensive substance use assessment
- Screening for substance use
- Interim services for clients
- Screening for mental disorders
- Screening for tobacco use
- In-network prescribing entity
- Disulfiram
- Buprenorphine with naloxone
- Naltrexone (oral)
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Acamprosate (Campral®)
- Nicotine replacement
- Buprenorphine without naloxone
- Clonidine
- Vaping not permitted
- Children/Adolescents
- Medication routinely used during detoxification
- Opioids detoxification
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Detoxification
- Substance use treatment
- Domestic violence services, including family or partner
- Early intervention for HIV
- Integrated primary care services
- Case management service
- Mental health services
- Suicide prevention services
- Social skills development
- Private non-profit organization
- Self-help groups
- Mentoring/peer support
- Assistance with obtaining social services
- Adolescents
- Clients with co-occurring mental and substance use disorders
- Group counseling
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Family counseling
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- Drug or alcohol urine screening
- HIV testing
- Testing for Hepatitis B (HBV)
- STD testing
- TB screening
- Testing for Hepatitis C (HCV)
- Breathalyzer or blood alcohol testing
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Spanish
- Sign language services for the deaf and hard of hearing
- Matrix Model
- Trauma-related counseling
- Relapse prevention
- Brief intervention
- Telemedicine/telehealth therapy
- Cognitive behavioral therapy
- Motivational interviewing
- Substance use disorder counseling
- National Committee for Quality Assurance (NCQA)
- The Joint Commission
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Female
- Male
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- In-network prescribing entity
- Smoking not permitted
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient detoxification
- Outpatient day treatment or partial hospitalization
- Regular outpatient treatment
- Outpatient
- Prescribes buprenorphine
- Buprenorphine detoxification
- Prescribes naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Private health insurance
- Medicare
Assessment/Pre-treatment
External Opioid Medications Source
Pharmacotherapies
Facility Vaping Policy
Age Groups Accepted
Detoxification (medical withdrawal) Services
Type of Care
Ancillary Services
Facility Operation (e.g., Private, Public)
Recovery Support Services
Special Programs/Groups Offered
Education and Counseling Services
Testing
Opioid Medications used in Treatment
Language Services
Treatment Approaches
License/Certification/Accreditation
Transitional Services
Gender Accepted
Type of Alcohol Use Disorder Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Smoking Policy
Medical Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Opioid Treatment
Payment/Insurance/Funding Accepted